Literature DB >> 109323

The incidence of complications during pregnancy after treatment of hyperprolactinemia with bromocriptine in patients with radiologically evident pituitary tumors.

S W Lamberts, J G Klijn, S A de Lange, R Singh, S Z Stefanko, J C Birkenhäger.   

Abstract

The course of pregnancy achieved after bromocriptine therapy is described in nine patients with radiologically evident prolactin-secreting pituitary tumors. In six patients no complications occurred. No changes in sellar size or secondary endocrine deficiencies developed. In three patients, however, complications developed between the 22nd and 24th weeks of pregnancy. Despite prior external pituitary irradiation, one patient developed transient bitemporal hemianopsia and one patient had apoplexy of the pituitary tumor with transient paresis of the left abducens nerve. A third patient developed parasellar expansion of the pituitary tumor with bone destruction and paresis of the right abducens and oculomotor nerves. After transsphenoidal surgery the paresis of both nerves disappeared. Microscopically, the tissue removed at surgery was a chromophobe adenoma with focal fibrosis and calcifications without recent hemorrhages. In the course of more than 100 pregnancies achieved in The Netherlands after bromocriptine therapy, five patients reportedly developed complications of the pituitary tumor. At present, patients in whom complications can be expected cannot be predicted by the size or configuration of the sella turicica or the magnitude of elevation of the plasma prolactin level. In two patients external pituitary irradiation did not prevent complications during pregnancy.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 109323     DOI: 10.1016/s0015-0282(16)44050-1

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  13 in total

Review 1.  Therapeutic applications of bromocriptine in endocrine and neurological diseases.

Authors:  K Y Ho; M O Thorner
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

Review 2.  Management of endocrine disorders in pregnancy. Part II. Pituitary, ovarian and adrenal disease.

Authors:  Z M van der Spuy; H S Jacobs
Journal:  Postgrad Med J       Date:  1984-05       Impact factor: 2.401

3.  The management of prolactin-secreting pituitary tumors.

Authors:  S R George; G N Burrow
Journal:  J Endocrinol Invest       Date:  1981 Oct-Dec       Impact factor: 4.256

4.  Growth of a microprolactinoma to a macroprolactinoma during estrogen therapy.

Authors:  M M Garcia; L P Kapcala
Journal:  J Endocrinol Invest       Date:  1995-06       Impact factor: 4.256

5.  Spontaneous regression of pituitary mass in temporal association with pregnancy.

Authors:  H Ikeda; Y Okudaira
Journal:  Neuroradiology       Date:  1987       Impact factor: 2.804

6.  Bromocriptine-induced regression of a suprasellar extending prolactinoma during pregnancy.

Authors:  T Bergh; S J Nillius; P Enoksson; L Wide
Journal:  J Endocrinol Invest       Date:  1984-04       Impact factor: 4.256

Review 7.  Diagnosis and management of prolactinomas.

Authors:  J R Dollar; R E Blackwell
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

Review 8.  Pituitary apoplexy during pregnancy: a rare, but dangerous headache.

Authors:  E Piantanida; D Gallo; V Lombardi; M L Tanda; A Lai; F Ghezzi; R Minotto; A Tabano; M Cerati; C Azzolini; S Balbi; F Baruzzi; F Sessa; L Bartalena
Journal:  J Endocrinol Invest       Date:  2014-06-11       Impact factor: 4.256

Review 9.  Diagnosis and drug therapy of prolactinoma.

Authors:  E Ciccarelli; F Camanni
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

10.  Pituitary apoplexy in pregnancy: A case series and literature review.

Authors:  Sophie Grand'Maison; Florence Weber; Marie-Josée Bédard; Michele Mahone; Ariane Godbout
Journal:  Obstet Med       Date:  2015-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.